Works by Wun, Ted

Results: 56
    1
    2
    3

    Purified Poloxamer 188 for Treatment of Acute Vaso-occlusive Crisis of Sickle Cell Disease.

    Published in:
    JAMA: Journal of the American Medical Association, 2001, v. 286, n. 17, p. 2099, doi. 10.1001/jama.286.17.2099
    By:
    • Orringer, Eugene P.;
    • Casella, James F.;
    • Ataga, Kenneth I.;
    • Koshy, Mabel;
    • Adams-Graves, Patricia;
    • Luchtman-Jones, Lori;
    • Wun, Ted;
    • Watanabe, Masayo;
    • Shafer, Frank;
    • Kutlar, Abdullah;
    • Abboud, Miguel;
    • Steinberg, Martin;
    • Adler, Brian;
    • Swerdlow, Paul;
    • Terregino, Carol;
    • Saccente, Suzanne;
    • Files, Beatrice;
    • Ballas, Samir;
    • Brown, Robert;
    • Wojtowicz-Praga, Slawomir
    Publication type:
    Article
    4

    A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease.

    Published in:
    Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-17
    By:
    • Wun, Ted;
    • Soulieres, Denis;
    • Frelinger, Andrew L.;
    • Krishnamurti, Lakshmanan;
    • Novelli, Enrico M.;
    • Kutlar, Abdullah;
    • Ataga, Kenneth I.;
    • Knupp, Charles L.;
    • McMahon, Lillian E.;
    • Strouse, John J.;
    • Zhou, Chunmei;
    • Heath, Lori E.;
    • Nwachuku, Chuke E.;
    • Jakubowski, Joseph A.;
    • Riesmeyer, Jeffrey S.;
    • Winters, Kenneth J.
    Publication type:
    Article
    5

    UC Davis CTSA: Coming of Age.

    Published in:
    CTS: Clinical & Translational Science, 2009, v. 2, n. 2, p. 98, doi. 10.1111/j.1752-8062.2009.00101.x
    By:
    • Asmuth, David;
    • Wun, Ted;
    • Mullen, Nicole;
    • Garcia, Eric;
    • Chedin, Erica;
    • Whitney, Erica;
    • Gillis, Michael;
    • Anderson, Kent;
    • Tarantal, Alice;
    • Kenyon, Nicholas;
    • Curry, Fitz-Roy;
    • Berglund, Lars
    Publication type:
    Article
    6
    7
    8

    Patient‐reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 9, p. 1066, doi. 10.1002/ajh.25880
    By:
    • Knisely, Mitchell R.;
    • Pugh, Norma;
    • Kroner, Barbara;
    • Masese, Rita;
    • Gordeuk, Victor;
    • King, Allison A.;
    • Smith, Sharon M.;
    • Gurney, James G.;
    • Adams, Robert;
    • Wun, Ted;
    • Snyder, Angela;
    • Glassberg, Jeffrey;
    • Shah, Nirmish;
    • Treadwell, Marsha
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease.

    Published in:
    British Journal of Haematology, 2011, v. 155, n. 2, p. 263, doi. 10.1111/j.1365-2141.2011.08827.x
    By:
    • Quinn, Charles T.;
    • Stuart, Marie J.;
    • Kesler, Karen;
    • Ataga, Kenneth I.;
    • Wang, Winfred C.;
    • Styles, Lori;
    • Smith-Whitley, Kim;
    • Wun, Ted;
    • Raj, Ashok;
    • Hsu, Lewis L.;
    • Krishnan, Suba;
    • Kuypers, Frans A.;
    • Setty, Yamaja;
    • Rhee, Seungshin;
    • Key, Nigel S.;
    • Buchanan, George R.
    Publication type:
    Article
    23
    24

    Platelet activation in patients with sickle cell disease.

    Published in:
    British Journal of Haematology, 1998, v. 100, n. 4, p. 741, doi. 10.1046/j.1365-2141.1998.00627.x
    By:
    • Wun, Ted;
    • Paglieroni, Teresa;
    • Rangaswami, Arun;
    • Hill Franklin, Patricia;
    • Welborn, Jeanna;
    • Cheung, Anthony;
    • Tablin, Fern
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50